Programme
Pharmaceutical companies have solely provided sponsorship for the ABS Conference 2026 through the purchase of exhibition space and/ or sponsored symposia and have had no further input into the arrangements or programme for the event. Sessions delivered with input from sponsors will always be marked on the programme. See the list of sponsors.
Monday 08 June
08:00 to 08:45
Personalising peri operative care for eligible patients in early stage triple-negative breast cancer (TNBC)
Professor Shelley Potter, Professor Ellen Copson
09:00 to 09:15
Hear what your nurses have to say: Results of the ABS national workforce survey
Mrs Katy Ellis
09:15 to 09:30
The national breast imaging academy - impact and future direction
Dr Mary Wilson
09:30 to 09:45
Delivery of oncology services
Dr Catherine Harper-Wynne
09:45 to 10:00
Delivery of pathology services
Dr Rahul Deb
10:00 to 10:15
Current challenges in service provision: Panel discussion
All Faculty
09:00 to 09:15
The MARECA study: Analysis of disease presentation and patient management
Mr Baek Kim
09:15 to 09:30
Second cancers in breast cancer survivors
Associate Professor Paul McGale
09:30 to 09:45
Causes of mortality after breast cancer
Mr Gurdeep S Mannu
09:45 to 10:00
Living with metastatic breast cancer
Dr Dan Monnery
10:00 to 10:15
Q&A panel discussion with speakers
All Faculty
09:00 to 09:10
Breast and axillary response according to tumour subtype in node positive breast cancer patients undergoing neoadjuvant chemotherapy: Insights from the first 1000 patients enrolled in ATNEC trial
Mr Emanuele Garreffa
09:10 to 09:20
Immune evasion in various biological subtypes of breast cancer : Contributing to the poorer prognostic outcome
Professor Diptendra K Sarkar
09:20 to 09:30
Immediate versus delayed symmetrisation of the contralateral breast after oncoplastic procedures: A systematic review and meta-analysis
Mr Hussain Abdulla
09:30 to 09:40
Breast-conserving surgery versus mastectomy in BRCA mutation carriers: A systematic review and meta-analysis of oncological outcomes
Mr Max Seabrook
09:40 to 09:50
International consensus on axillary de-escalation after enhancing breast cancer surgical throughput: A staffing-driven quality improvement initiative
Mr James Lucocq
09:50 to 10:00
Breast conserving surgery versus mastectomy for multiple ipsilateral breast cancers: A systematic review and meta-analysis
Reem Althawadi
10:00 to 10:10
SENTINUS: Technical feasibility and diagnostic accuracy of intradermal microbubbles and contrast enhanced ultrasound (CEUS) to identify sentinel lymph node (SLN)
Miss Karina Cox
10:25 to 10:45
Top tips for writing an abstract
Miss Jenna Morgan
10:55 to 11:10
Variations in risk factor profiles for breast cancer by ethnicity and implications for incidence
Associate Professor Toral Gathani
11:10 to 11:25
Social determinants of health
Professor Linda Sharp
11:25 to 11:40
Addressing inequalities
Ms Jo Trask
11:40 to 11:55
Shades of survival: Advocating for equity and amplifying lived experience through film
Hilary Moore
11:55 to 12:10
Q&A panel discussion
All Faculty
10:55 to 11:15
How will I know if it's a good unit to join?
Professor Kieran Horgan
11:15 to 11:30
Evolution of oncoplastic surgery training
Ms Sarah Downey
11:30 to 11:45
Delivery of reconstructive surgery
Mr Andy Malyon
11:45 to 12:00
GIRFT data: Are we where we need to be?
Miss Tracey Irvine
12:00 to 12:10
Q&A panel discussion with speakers
All Faculty
10:55 to 11:10
Addressing inequality: Ensuring patient access to trials
Mr Henry Cain
11:10 to 11:25
ASPIRE initial results: Managing breast pain referrals safely and effectively
Mr Rajiv Dave, Ms Jennifer Hu
12:25 to 12:40
Maximising decisions for breast conservation: Mastectomy avoidance tool
Miss Hannah Lennon
12:40 to 11:55
Breast cancer personalised risk: Building a high-risk prevention programme
Professor Tari King
11:55 to 12:05
Submitted paper: Breast clinical nurse specialists (CNS) led implementation of R208 mainstream genetic testing – does it add value to a UK breast service?
Miss Muskaan Khosla
12:25 to 12:55
Unravelling the lobular phenotype
Professor Tari King
13:10 to 14:10
Surgical de-escalation and genomic testing for HR+, HER2- early stage breast cancer patients Surgical and Oncological perspective - Exploring the data
Professor PG Roy, Dr Mark Verrill
13:15 to 13:35
Private practice – challenging the status quo
Mr Charlie Chan
13:30 to 13:50
Applying for a grant
Miss Kit Fairhurst
13:40 to 13:55
Enhancing the multidisciplinary team: The MDT toolkit
Mr Sumohan Chatterjee
14:15 to 14:30
Is all LCIS the same?
Professor Tari King
14:30 to 14:45
Monitoring patients with previous supradiphargmatic radiotherapy
Dr William Teh
14:45 to 15:00
COMET and LORIS trials
Professor Cliona Kirwan
15:00 to 15:15
B3 guidelines what is there in the literature
Professor Abeer Shaaban
15:15 to 15:30
Q&A panel discussion with speakers
All Faculty
14:15 to 14:30
Breast cancer in young women – considerations for treatment
Professor Carlo Palmieri
14:30 to 14:45
The good, the bad, and the ugly: Cancer at 37
Ms Alona Courtney
14:45 to 15:00
Fertility
Dr Aparna Sastry
15:00 to 15:30
MDT panel discussion
Professor Carlo Palmieri, Ms Alona Courtney, Mrs Estelle Rachael Flynn, Professor Zosia Miedzybrodzka, Professor Jana de Boniface
14:15 to 14:30
EBCTCG update
Dr David Dodwell
14:30 to 14:45
Clinician-light end-to-end pathway for delivery of NHS diagnostic BRCA-gene testing
Professor Clare Turnbull
14:45 to 15:00
PRADA II & MAMMA_VAD update
Professor Daniel Leff
15:00 to 15:10
Submitted paper: Performance of axillary node localisation techniques following neoadjuvant chemotherapy: A multicentre analysis of the ATNEC trial
Miss Lisa Sheehan
15:10 to 15:20
Submitted paper: Association between 11 high- and moderate-risk breast cancer predisposition genes and survival in young-onset breast cancer: A prospective cohort study (POSH)
Mr Wilson Cheah
15:20 to 15:30
Submitted paper: The pink corridor program: A scalable hub-and-spoke model for breast cancer population screening and early detection program in a high-density LMIC setting
Professor Diptendra K Sarkar
15:40 to 15:53
Low Rates of Capsular Contracture and Reoperation at Five Years With the PERLE™ Implant
Mr James Lucocq
16:15 to 16:30
From complication to correction: A strategy for patient assessment
Mrs Isabella Karat
16:30 to 16:45
Revising the unintended result: How to plan and measure
Professor PG Roy
16:45 to 17:00
Revisionary techniques in oncoplastic breast surgery: What are the options?
Mr Richard Sutton
17:00 to 17:30
Case discussion panel
Professor Alberto Rancati, Mrs Isabella Karat, Professor PG Roy, Mr Richard Sutton
16:15 to 16:30
Update in breast screening
Dr Jonathan James
16:30 to 16:45
Breast density - role of functional imaging
Professor Fiona Gilbert
16:45 to 17:00
Results from the AVOID audit and imaging management of the axilla
Dr Nisha Sharma
17:00 to 17:15
AI for breast cancer screening: From detection to risk prediction
Professor Yan Chen
17:15 to 17:30
Q&A panel discussion with speakers
All Faculty
16:15 to 16:25
The NHS 111 online self referral pathway pilot in Somerset- a year on
Miss Maria Bramley
16:25 to 16:35
Prospective validation of a novel composite metric integrating clinical risk, imaging biomarkers, and lifestyle factors for breast cancer risk stratification
Dr Saturnino Domínguez
16:35 to 16:45
Enhancing breast cancer surgical throughput: A staffing-driven quality improvement initiative
Miss Anamaria Schipor
16:45 to 16:55
The impact of incisional negative-pressure therapy on abdominal donor-site in DIEP flap breast reconstruction: A large-scale analysis
Dr Komal Saeed
16:55 to 17:05
Enhancing breast cancer margin detection with 5-ALA-induced fluorescence
Miss Naomi Laskar
17:05 to 17:15
Mammaglobin - A expression in breast cancer pathology and 15-year survival
Dr Liz Baker
17:15 to 17:25
Axilla redefined: Functional zonal anatomy revealing an arm specific, metastasis free nodal basin
Dr Ronit Roy
17:25 to 17:35
National United Kingdom study of the management of breast cancer locoregional recurrence and oncological outcomes (MARECA) study: Analysis of disease presentation and patient management
Miss Jenna Morgan
16:15 to 16:30
Absolute versus relative risk explained
Dr Sue Hartup
16:30 to 17:30
Panel discussion
Mrs Jo Fields, Professor Lynda Wyld, Dr Sue Hartup, Professor Carlo Palmieri
17:40 to 18:00
ABS and Mammary Fold Awards: Lifetime achievement and trainer of the year
Mr Yazan Masannat, Ms Sarah Downey, Miss Buket Ertansel
18:00 to 18:05
Reconstruction matters: Breast-Q outcomes favours local perforator flap reconstruction over mastectomy
Ms Sadia Jaskani
18:05 to 18:10
Neo-adjuvant chemotherapy and reduced reoperation rates after breast conservation surgery in England
Dr Jemma Boyle
18:10 to 18:15
Breast oncology multidisciplinary immersion week: A retrospective evaluation of technical feasibility and educational impact
Mr Ravi Naik
18:15 to 18:20
Can Oncotype DX guide frequency of surveillance mammograms?
Miss Yan Yu Tan
18:20 to 18:25
Incidence of contralateral breast cancer and radiological diagnosis in invasive lobular carcinoma; a single-centre study
Speaker To Be Confirmed
18:25 to 18:30
Perioperative investigation and correction of iron-deficiency anaemia in patients undergoing breast surgery, post-neoadjuvant chemotherapy: A cross-trust study in North West England (2020-2025)
Miss Naveena Kaur Rikhraj
18:30 to 18:35
Implant loss and salvage in implant-based breast reconstruction: A single-centre retrospective audit
Dr Charles King
18:35 to 16:40
How well do we prepare patients for shoulder exercises after breast cancer axillary surgery? A prospective snapshot survey
Dr Delilah Rees
Tuesday 09 June
08:00 to 08:45
Bridging the Atlantic: Shared Magtrace Workflow learnings from the US and UK
TBC
08:30 to 08:35
Breast tumours in males
Mohammed Gouse Mohiddin
08:35 to 08:40
Single-port endoscopic nipple – sparing mastectomy with the HandXTM hand-held articulating system
Dr Vasileios Kalles
08:40 to 08:45
Hidden scar nipple sparing mastectomy and direct to implant reconstruction - Video with assessment of complications, oncological outcomes and aesthetic outcome
Mr John Mathew
09:00 to 09:15
Two stage reconstruction
Dr Antonio Tejerina
09:15 to 09:30
Polyurethane implants do we need ADMs at all
Professor Alberto Rancati
09:30 to 09:40
What surgeons need to know about ALCL
Mr Jamie Vatish
09:40 to 09:50
Setting up an ALCL MDT
Mr Aadil Khan
09:50 to 10:15
Q&A panel discussion with speakers
All Faculty
09:00 to 09:15
Lifestyle measures
Professor Marjolein Smidt
09:15 to 09:30
Importance of exercise
Professor John Saxton
09:30 to 09:45
APPROACH: An app plus behavioural support to promote physical activity as part of cancer care
Professor Abigail Fisher
09:45 to 09:55
Cando3 – trial update
Dr Robert Kemp
09:55 to 10:15
Q&A panel discussion with speakers
All Faculty
09:00 to 09:15
Oncoplastic fellowships in the UK
Professor Lynda Wyld
09:15 to 09:30
Trainees in research (MFAC)
Ms Anna Isaac, Mr Gareth Irwin
09:30 to 09:45
The training survey and training passport update
Dr Ashrafun Nessa
09:45 to 10:15
Q&A panel discussion
All Faculty
10:25 to 10:55
Not all mastectomies are the same
Professor Alberto Rancati
11:05 to 11:18
Optimising Mastopexy Outcomes Using Poly 4 Hydroxybutyrate (P4HB)
Mr Mark Ho-Asjoe
11:10 to 11:30
Collaborative European research
Professor Jana de Boniface, Professor Marjolein Smidt
11:30 to 11:45
Oncology and treatment side effects
Dr Suzy Cleator
11:45 to 12:00
Surgery: Is conservation an option
Mr Ross McLean
12:00 to 12:15
My experience as a male breast cancer patient
Mr Richard Galloway
12:15 to 12:30
Supporting men with breast cancer: Psychosocial insights and clinical implications
Dr Kerry Quincey
12:30 to 12:45
Q&A panel discussion with speakers
All Faculty
11:30 to 11:45
Understanding resistance in triple negative breast cancer
Dr Stephen Sammut
11:45 to 12:00
New therapeutic approaches for ER+ HER2- Breast cancer (CDK4/5, oral new oral SERDs, ESR1 testing)
Dr Olga Oikonomidou
12:00 to 12:15
HER2 positive disease update
Professor Iain Macpherson
12:15 to 12:30
Do all ER positive, HER2 positive need chemotherapy
Professor Carlo Palmieri
12:30 to 12:45
Q&A panel discussion
All Faculty
11:30 to 11:40
Embedding the environmental impact estimation in breast surgery: a modular hybrid blueprint for surgical pathway carbon footprinting
Mr Aws Almukhtar
11:40 to 11:50
3D surface imaging and simulation in immediate breast reconstruction - The MIBREAST randomised trial
Miss Astrid Leusink
11:50 to 12:00
Margin positivity in breast-conserving surgery after neoadjuvant chemotherapy: A systematic review and meta-analysis
Ms Niamh Keating
12:00 to 12:10
Temporal trends in neo-adjuvant chemotherapy use for early breast cancer in England: a population-based study
Dr Jemma Boyle
12:10 to 12:20
Body mass index, mammographic density and post-menopausal breast cancer risk: a mediation analysis
Dr Benoit Jauniaux
12:20 to 12:30
Is PET/CT an accurate tool to detect nodal pathological response in breast cancer: A comparative analysis of upfront surgery versus neoadjuvant settings
Dr Sheena Wadhwa
12:30 to 12:40
Wearable motion analysis objectively quantifies functional recovery after breast cancer surgery: findings from a feasibility randomised trial
Mr Ahmed Latif
12:55 to 13:55
When is less really more? Redefining axillary management in early breast cancer
Dr Rahul Deb, Professor Shelley Potter, Dr Nisha Sharma, Dr David Dodwell, Professor Carlo Palmieri
13:00 to 13:20
How to write a business case (and be successful)
Professor Christopher Holcombe
13:30 to 13:50
Video technical skills
Professor Alberto Rancati, Dr Antonio Tejerina
14:05 to 14:35
Cancer: Why me?
Miss Leena Chagla
14:45 to 15:15
Mastectomy should not be an option when breast conservation is possible
Mr Henry Cain, Professor Jana de Boniface
15:15 to 15:45
Prepectorial has replaced submuscular reconstruction as the operation of choice
Professor Shelley Potter, Dr Antonio Tejerina
15:45 to 15:10
Q&A panel discussion with speakers
All Faculty
14:45 to 15:00
HRT after breast cancer diagnosis
Dr Charlotte Gooding
15:00 to 15:15
From physical changes to emotional response, sex and relationships after breast cancer
Caroline Wilson
15:15 to 15:30
Unpacking cancer‑related fatigue after (breast) cancer: what might be driving it?
Dr Jeanne Dekerle
15:30 to 15:45
Managing sleep
Dr Lindsay Browning
15:45 to 16:00
Q&A panel discussion
All Faculty
